FDA Inspection 1022670 — E-Liquid Therapeutics, Inc.

E-Liquid Therapeutics, Inc. — FEI 3013154048

The FDA completed an inspection of E-Liquid Therapeutics, Inc. on Aug 1, 2017 in Fremont, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Tobacco.

Inspection details

Classification
No Action Indicated (NAI)
End Date
Aug 1, 2017
Fiscal Year
2017
Product Type
Tobacco
Project Area
Tobacco Post-Market Activities
Location
Fremont, CA (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.